These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 3657146

  • 1. Desmethylnafoxidine aziridine: an electrophilic affinity label for the estrogen receptor with high efficiency and selectivity.
    Simpson DM, Elliston JF, Katzenellenbogen JA.
    J Steroid Biochem; 1987 Sep; 28(3):233-45. PubMed ID: 3657146
    [Abstract] [Full Text] [Related]

  • 2. [125I]iododesethyl tamoxifen aziridine: synthesis and covalent labeling of the estrogen receptor with an iodine-labeled affinity label.
    Salituro FG, Carlson KE, Elliston JF, Katzenellenbogen BS, Katzenellenbogen JA.
    Steroids; 1986 Sep; 48(5-6):287-313. PubMed ID: 3445283
    [Abstract] [Full Text] [Related]

  • 3. Ketononestrol aziridine, an agonistic estrogen receptor affinity label: study of its bioactivity and estrogen receptor covalent labeling.
    Elliston JF, Zablocki JA, Katzenellenbogen BS, Katzenellenbogen JA.
    Endocrinology; 1987 Aug; 121(2):667-76. PubMed ID: 3595536
    [Abstract] [Full Text] [Related]

  • 4. Unique molecular properties of a urea- and salt-stable DNA-binding estrogen receptor dimer covalently labeled with the antiestrogen [3H]desmethylnafoxidine aziridine. A comparison with the estrogen-receptor complex.
    Hutchens TW, McNaught RW, Yip TT, Suzuki T, Li CM, Besch PK.
    Mol Endocrinol; 1990 Feb; 4(2):255-67. PubMed ID: 2330004
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Biological activities of tamoxifen aziridine, an antiestrogen-based affinity label for the estrogen receptor, in vivo and in vitro.
    Wei LL, Mangel WF, Katzenellenbogen BS.
    J Steroid Biochem; 1985 Dec; 23(6A):875-81. PubMed ID: 3937947
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Identification of cysteine 530 as the covalent attachment site of an affinity-labeling estrogen (ketononestrol aziridine) and antiestrogen (tamoxifen aziridine) in the human estrogen receptor.
    Harlow KW, Smith DN, Katzenellenbogen JA, Greene GL, Katzenellenbogen BS.
    J Biol Chem; 1989 Oct 15; 264(29):17476-85. PubMed ID: 2793867
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of nafoxidine on the luteinizing hormone surge: temporal distribution of estrogen receptors and induction of cytoplasmic progestin receptors in the hypothalamus-preoptic area, pituitary, and uterus of the immature rat.
    Attardi B, Palumbo LA.
    Endocrinology; 1981 Nov 15; 109(5):1365-74. PubMed ID: 7297482
    [Abstract] [Full Text] [Related]

  • 15. A comparison of 11 beta-chloromethylestradiol and tamoxifen aziridine as affinity labeling reagents for estrogen receptors.
    Ratajczak T, Atrache V, Antes P, Comber M, Hähnel R.
    Steroids; 1988 Nov 15; 51(5-6):499-518. PubMed ID: 3242173
    [Abstract] [Full Text] [Related]

  • 16. Nuclear mechanisms of estrogen action. Effects of estradiol and anti-estrogens on estrogen receptors and nuclear receptor processing.
    Horwitz KB, McGuire WL.
    J Biol Chem; 1978 Nov 25; 253(22):8185-91. PubMed ID: 711743
    [No Abstract] [Full Text] [Related]

  • 17. Nonsteroidal estrogens bearing acyl azide functions: potential electrophilic and photoaffinity labeling agents for the estrogen receptor.
    Pinney KG, Carlson KE, Katzenellenbogen JA.
    Steroids; 1992 May 25; 57(5):222-32. PubMed ID: 1488784
    [Abstract] [Full Text] [Related]

  • 18. Chemical probes of estrogen action: affinity labeling.
    Katzenellenbogen JA, Carlson KE, Johnson HJ, Myers HN.
    J Toxicol Environ Health Suppl; 1976 May 25; 1():205-30. PubMed ID: 1033295
    [Abstract] [Full Text] [Related]

  • 19. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.
    Reiner GC, Katzenellenbogen BS, Bindal RD, Katzenellenbogen JA.
    Cancer Res; 1984 Jun 25; 44(6):2302-8. PubMed ID: 6547074
    [Abstract] [Full Text] [Related]

  • 20. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA, Lippman ME, Katzenellenbogen BS.
    Cancer Res; 1984 Nov 25; 44(11):5038-45. PubMed ID: 6488162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.